These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12949565)

  • 1. Arraying autoimmunity treatment.
    Sercarz EE
    Nat Biotechnol; 2003 Sep; 21(9):1017-9. PubMed ID: 12949565
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
    Robinson WH; Fontoura P; Lee BJ; de Vegvar HE; Tom J; Pedotti R; DiGennaro CD; Mitchell DJ; Fong D; Ho PP; Ruiz PJ; Maverakis E; Stevens DB; Bernard CC; Martin R; Kuchroo VK; van Noort JM; Genain CP; Amor S; Olsson T; Utz PJ; Garren H; Steinman L
    Nat Biotechnol; 2003 Sep; 21(9):1033-9. PubMed ID: 12910246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Autoimmunity and nervous diseases].
    Lehoczky T
    Munch Med Wochenschr; 1966 Aug; 108(31):1518-22 passim. PubMed ID: 4169913
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection from autoimmunity by DNA vaccination against T-cell receptor.
    Buch T; Waisman A
    Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspects of the value of humoral antibodies in encephalomyelitis of neuroallergic origin].
    Hitzschke B; Günther J; Meyer-Rienecker HJ
    Psychiatr Neurol Med Psychol (Leipz); 1975 Jan; 27(1):1-15. PubMed ID: 178016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis and neuritis: immunologic responses to myelin basic proteins.
    Brostoff SW
    Birth Defects Orig Artic Ser; 1978; 14(5):245-60. PubMed ID: 687794
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Immunologic mysteries of multiple sclerosis.
    Waksman BH
    N Engl J Med; 1974 Jul; 291(1):45-6. PubMed ID: 4832403
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Vaccination Techniques.
    Fissolo N; Montalban X; Comabella M
    Methods Mol Biol; 2016; 1304():39-50. PubMed ID: 24973869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies of the allergic nature of multiple sclerosis and the commencement of therapeutic trials.
    Campbell B; Vogel PJ; Fisher E; Lorenz R
    Trans Am Neurol Assoc; 1970; 95():192-5. PubMed ID: 5514365
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 1 interferons cool the inflamed brain.
    Axtell RC; Steinman L
    Immunity; 2008 May; 28(5):600-2. PubMed ID: 18482563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
    Haghikia A; Gold R
    Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory disease: assault on the guardian.
    Ransohoff RM
    Nature; 2007 Jul; 448(7152):421-2. PubMed ID: 17653181
    [No Abstract]   [Full Text] [Related]  

  • 18. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
    Bolton C
    Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis.
    Ransohoff RM
    Trends Immunol; 2006 Apr; 27(4):167-8. PubMed ID: 16513422
    [No Abstract]   [Full Text] [Related]  

  • 20. Animal models: Not close enough.
    Rice J
    Nature; 2012 Apr; 484(7393):S9. PubMed ID: 22509510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.